Deal Announcements

Aureon Biosciences Collects Venture Capital Debt

Monday, October 03, 2011 5:30:00 AM PDT | VentureDeal Staff

Yonkers, New York  --  Medical device treatment company Aureon Biosciences has secured $3.8 million in new venture capital debt, according to an SEC regulatory filing.

Aureon has developed technology that provides personalized results by analyzing patient biopsy samples using molecular diagnostics.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1